Andreas Rimner, MD

Andreas Rimner, MD, is an Associate Attending and the Director of Thoracic Radiation Oncology Research at Memorial Sloan Kettering Cancer Center. He specializes in treating thoracic malignancies, including lung cancer, malignant pleural mesothelioma (MPM) and thymic tumors. He is also the Thoracic Track Chair of the Annual Meeting of ASTRO, ABR board member for Thoracic Cancers and Sarcomas, Vice President of ITMIG, Board Member of IMIG and Member of the IASLC Staging and Prognostic Factors Committee. He is the Principal Investigator of 8 ongoing prospective clinical trials and has been invited nationally and internationally for lectures on thoracic radiation therapy progress and combination therapies with novel systemic treatment agents.

Disclosures:

• Employment: Universitaetsklinik Freiburg:Vice Chair:Employee
• Compensation: Varian Medical Systems: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: 2023 ;Boehringer Ingelheim: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: 2023 ;Astra Zeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Research Grants, Research Funding, Research Salary Support,Grant Research Funding, Honoraria-End Date: to present ;Merck: Advisory Board, Advisory Board Type, Advisory
• Ownership: none
• Leadership: International Thymic Malignancies Interest Group:Vice President;International Mesothelioma Interest Group:Board Member